Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter]

por Rege, Bhaskar, Meyer, Jonathan M
Publicado 2023

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

por Meyer, Jonathan M., Correll, Christoph U.
Publicado 2023

Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia

por Meyer, Jonathan M., Mao, Yongcai, Pikalov, Andrei, Cucchiaro, Josephine, Loebel, Antony
Publicado 2015

Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing

por Moore, Bret A., Morrissette, Debbi A., Meyer, Jonathan M., Stahl, Stephen M.
Publicado 2017

Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records

por Meyer, Jonathan M., Ng-Mak, Daisy S., Chuang, Chien-Chia, Rajagopalan, Krithika, Loebel, Antony
Publicado 2017

Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction

por Meyer, Jonathan M., Proctor, George, Cummings, Michael A., Dardashti, Laura J., Stahl, Stephen M.
Publicado 2016

A survey of personnel and services offered in 32 outpatient US clozapine clinics

por Cotes, Robert O., Rolin, Donna, Meyer, Jonathan M., Young, Alexander S., Cohen, Amy N., Gorrindo, Tristan
Publicado 2021

Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other...

por Correll, Christoph U, Jain, Rakesh, Meyer, Jonathan M, Periclou, Antonia, Carrothers, Timothy, Barabássy, Ágota, Patel, Mehul, Earley, Willie
Publicado 2019

Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice

por Hauser, Robert A., Meyer, Jonathan M., Factor, Stewart A., Comella, Cynthia L., Tanner, Caroline M., Xavier, Rose Mary, Caroff, Stanley N., Lundt, Leslie
Publicado 2022

Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

por Doane, Michael J., Bessonova, Leona, Friedler, Haley S., Mortimer, Kathleen M., Cheng, Harry, Brecht, Thomas, O’Sullivan, Amy K., Cummings, Hannah, McDonnell, David, Meyer, Jonathan M.
Publicado 2022